Lv11
40 积分 2025-04-30 加入
Vorasidenib in IDH1-mutant or IDH2-mutant low-grade glioma (INDIGO): secondary and exploratory endpoints from a randomised, double-blind, placebo-controlled, phase 3 trial
2个月前
已完结
Immunotherapy for hepatocellular carcinoma
7个月前
已完结
Endometriosis-associated Serous Borderline Tumor and Endometrial Stromal Sarcoma of the Ovary
8个月前
已完结
Liquid Biopsy Detects Early Molecular Response and Predicts Benefit to First-Line Chemotherapy plus Cetuximab in Metastatic Colorectal Cancer: PLATFORM-B Study
8个月前
已完结
皖公网安备34019202002308
